Five bills in the Oregon legislature name the 340B program. Two became law. Here is what each one is, how far it has got and where to read it.
2025 Regular Session
Ended 30 June 2025
About 340B
Contract pharmacy access
HB 2385Relating to restrictions on 340B covered entities; and prescribing an effective date.
Bars drug makers from denying or restricting delivery of 340B drugs to a pharmacy under contract with a covered entity, and from requiring claims or utilization review data as a condition. The state pharmacy board may fine a drug maker up to $5,000 a day for each violation.
Became law11 June 2025
Latest step
24 June 2025: Chapter 297, (2025 Laws): effective on the 91st day following adjournment sine die.
Sponsor
Rob Nosse; Deb Patterson, with 6 cosponsors
Introduced
13 January 2025
Where it names 340B: HB 2385
… GAMBA, GOMBERG, JAVADI, PHAM H, Senator MANNING JR (Presession filed.) CHAPTER ................................................. AN ACT Relating to restrictions on 340B covered entities; and prescribing an effective date. Be It Enacted by the People of the State of Oregon: SECTION 1. (1) As used in this section: (a) “Covered entity” …
HB 2057Relating to prescription drugs; prescribing an effective date.
Would bar insurers and pharmacy benefit managers from requiring a claim to carry a marker showing that the drug is a 340B drug, except for Medicaid claims or where the law requires the marker to prevent a duplicate discount.
Introduced13 January 2025Session ended 30 June 2025
Latest step
28 June 2025: In committee upon adjournment.
Sponsor
Rob Nosse, with 2 cosponsors
Where it names 340B: HB 2057
… statement includes a measure digest written in compliance with applicable readability standards. Digest: Tells insurers and PBMs not to require that drugs be labeled as 340B drugs in a claim for repayment. (Flesch Readability Score: 62.8). Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers …
SB 533Relating to restrictions on 340B covered entities.
Would bar drug makers from interfering with a contract pharmacy acquiring, receiving or dispensing 340B drugs for a covered entity, and from requiring claims or utilization review data as a condition. The pharmacy board could fine a drug maker up to $5,000 per day.
Introduced13 January 2025Session ended 30 June 2025
Latest step
27 June 2025: At President's desk upon adjournment.
Sponsor
Deb Patterson; Rob Nosse; James Manning Jr.
Where it names 340B: SB 533
… for violations. (Flesch Readability Score: 60.8). Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to …